Surgery News and Research

RSS

Breast cancer patients more likely to have joint pain from taking AIs: Study

Breast cancer patients are more likely to have joint pain from taking aromatase inhibitors if they have advanced stage cancer, according to a study presented at the American College of Rheumatology's annual meeting, held Nov. 7-11, in Atlanta. The study is one of the first to identify factors that increase the likelihood that a patient will suffer joint pain from AI therapy.

10 Nov 2010

New type of heart pump for infants born with univentricular circulation

Researchers have created a new type of heart pump inserted with a catheter to improve the survival rate for infants undergoing a series of surgeries to correct a deadly birth defect.

10 Nov 2010

Study sheds light on difficulty of controlling blood pressure in patients with high aldosterone levels

A hormone already responsible for increasing blood pressure by prompting the kidneys to retain salt appears to moonlight as a major stimulator of the brain centers that control the vascular system and blood pressure.

10 Nov 2010

Accreditation Council for Graduate Medical Education to honor LA BioMed researcher

The Accreditation Council for Graduate Medical Education will honor Christian de Virgilio, MD, a principal investigator at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), with its Parker J. Palmer Courage to Teach Award for Program Director Excellence at its 2011 awards ceremony in Nashville, Tenn.

10 Nov 2010

Special Surgery investigators to present future of clinical care at ACR annual meeting

Hospital for Special Surgery physicians who focus on lupus, scleroderma and related conditions are traveling from New York City to Atlanta this week to share their recent findings at the 74th Annual Scientific Meeting of the American College of Rheumatology (ACR).

10 Nov 2010

New robotic surgery technique for kidney cancer reduces organ damage

A new method of surgery for kidney cancer could help reduce organ damage, leading to more successful treatment of the disease, scientists have discovered.

10 Nov 2010

Restylane boosts people's first impression

A recent study demonstrating that the treatment of nasolabial folds with Restylane positively influences the first impression that an individual projects was published by Dr. Steven Dayan (www.drdayan.com) and DeNova research in the November 2010 issue of Dermatologic Surgery, a leading Dermatology journal. In a study 20 patients received Restylane the popular hyaluronic filler to fill in the nasolabial folds which run from the side of the nose to the side of the mouth.

10 Nov 2010

Adolescent obesity associated with risk of severe obesity in adulthood

Obese adolescents are 16 times more likely to become severely obese by age 30 than their healthy weight or even overweight peers, according to a new study from the University of North Carolina at Chapel Hill.

10 Nov 2010

MicroAire and Arthrex enter agreement to settle ECTR patent infringement suit

MicroAire Surgical Instruments LLC and Arthrex Inc. announced today that they have entered an agreement to settle a suit accusing Arthrex of patent infringement and breach of contract. At issue was the patented technology that MicroAire owns for minimally invasive treatment of Carpal Tunnel Syndrome.

10 Nov 2010

Human blood from adult human skin

In an important breakthrough, scientists at McMaster University have discovered how to make human blood from adult human skin.

9 Nov 2010

Angiotech reports $59.0 million total revenue for third quarter 2010

Angiotech Pharmaceuticals, Inc. today announced that it had released its financial results for the third quarter ended September 30, 2010.

9 Nov 2010

Biologic grafts are increasingly being used to repair complex hernias

Surgical residents in their final years of surgical training learned the latest techniques in using biologic grafts to treat hernias in a workshop led by the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), and sponsored through an educational grant from Cook Medical.

9 Nov 2010

New techniques to stop ventricular arrhythmias in high-risk patients

New techniques now being used at UCLA allow doctors to more precisely target certain areas of the heart to stop ventricular arrhythmias — serious abnormal rhythms in the heart's lower chambers — in high-risk patients.

9 Nov 2010

Only 50% of lung cancer patients in England are getting lifesaving surgery

Only half as many lung cancer patients in England are getting potentially lifesaving surgery compared to the best countries in the world, according to a new report by the National Cancer Intelligence Network (NCIN).

9 Nov 2010

Patients undergoing THR likely to have serious falls than orthopedic procedure

Patients who undergo total hip replacements are more at risk for having a serious fall while recovering in the hospital than patients undergoing other orthopedic procedures, according to a recent study. The study, which will be presented at the American College of Rheumatology's annual meeting, Nov. 7-11, in Atlanta, also identified other factors involved in patient falls that could help hospitals devise strategies to reduce these accidents.

9 Nov 2010

Multidetector CT helps pinpoint causes of ischemic stroke

Multidetector computed tomography (CT) helps pinpoint the causes of ischemic strokes, the most common type of stroke, potentially speeding the delivery of life-saving treatments, according to a study published online and in the January issue of Radiology.

9 Nov 2010

Intercell aggregate revenues decrease 28.4% to EUR 21.1m in 9 months ended September 30, 2010

Today, Intercell AG announced its financial results for the third quarter of 2010 and presented an update on the Company's key R&D programs as well as changes to the Management Board.

9 Nov 2010

Chemotherapy for breast cancer does more harm than good

A fundamental principle of medicine is: "first, do no harm." However, for doctors who treat breast cancer, this is easier said than done. Every year, almost 22,000 Canadian women are diagnosed with breast cancer - their treatment usually involves surgery to remove a tumour and then chemotherapy to reduce the risk of cancer returning.

9 Nov 2010

Valley Anesthesiology Consultants' mobile services division receives AAAHC accreditation

VAC Mobile Services, a division of Valley Anesthesiology Consultants, has achieved accreditation by the Accreditation Association for Ambulatory Health Care (AAAHC). Valley is one of only 10 office-based anesthesia groups nationwide to receive AAAHC accreditation, and the only office-based anesthesia organization in Arizona currently accredited by AAAHC.

9 Nov 2010

Genta commences tesetaxel Phase 2b clinical trial as 1st-line chemotherapy for metastatic breast cancer

Genta Incorporated today announced that the Company has initiated a new Phase 2b clinical trial of tesetaxel as 1st-line chemotherapy for women with metastatic breast cancer. Tesetaxel is the leading oral taxane currently in clinical development. The new trial will be conducted at Memorial Sloan-Kettering Cancer Center, New York, NY and at the Accelerated Community Oncology Research Network (ACORN) based in Memphis, TN.

9 Nov 2010